GlassScriptPhysician profile
Laura J Raid Witthoeft
NPI 1164429254
$771.64
in general payments reported to CMS, 2019-2025
18 companies · $207 in 2025
The $207 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $19.08 · 2023: $250 · 2024: $174 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $630.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $172.49 | 2023-2025 | Veozah |
| Abbvie INC. | $112.18 | 2019-2025 | |
| Hologic Sales and Service, LLC | $87.48 | 2023-2025 | Acessa Provu System, Myosure Tissue Removal Device |
| Bayer Healthcare Pharmaceuticals INC. | $43.57 | 2019 | |
| Axonics, INC. | $41.81 | 2024 | Bulkamid, Axonics |
| Merck Sharp & Dohme LLC | $38.14 | 2024 | Gardasil, Gardasil 9 |
| Organon LLC | $36.95 | 2023-2025 | Nexplanon |
| Daiichi Sankyo INC. | $35.32 | 2019-2023 | Injectafer |
| Biogen, INC. | $35.07 | 2025 | Zurzuvae |
| Pfizer INC. | $33.55 | 2023 | |
| Medtronic, INC. | $24.38 | 2023 | V-Loc 180 |
| Vertex Pharmaceuticals Incorporated | $18.59 | 2025 | |
| Exact Sciences Corporation | $18.22 | 2023 | Cologuard Collection Kit |
| Laborie Medical Technologies Corp. | $17.30 | 2024 | Kiwi Procup |
| Medline Industries LP | $15.65 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $14.38 | 2019 | |
| Smith+Nephew, INC. | $13.37 | 2023 | Pico 7, Renasys Go V2 Home |
| Coopersurgical, INC. | $13.19 | 2024 | Paragard T 380a |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Raid Witthoeft listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.